Publications


Books

Vaccines, Medicines and COVID-19
How Can WHO Be Given a Stronger Voice?

 Springer, 2022
Author: Germán Velásquez
Access to Medicines and Vaccines
 Implementing Flexibilities Under Intellectual Property Law

Springer 2021
Editors: Carlos M. Correa and Reto M. Hilty
Uso Público No Comercial y Licencias Obligatorias en América Latina: Estado de Situación

 South Centre, Ginebra, 2021
Autor: Guillermo Vidaurreta
View all books

Policy Briefs

La incorporación de la equidad en el Reglamento Sanitario Internacional y en futuros instrumentos jurídicos de la OMS sobre preparación y respuesta frente a pandemias
 Informe sobre políticas No. 108, 25 de marzo de 2022

Nirmalya Syam
L’intégration de l’équité dans le Règlement sanitaire international et les futurs instruments juridiques de l’OMS sur la préparation et la riposte aux pandémies
 Rapport sur les politiques No. 108, 25 mars 2022

Nirmalya Syam
Analysis of the Outcome Text of the Informal Quadrilateral Discussions on the TRIPS COVID-19 Waiver
 Policy Brief 110, 5 May 2022

Carlos M. Correa and Nirmalya Syam
View all policy briefs

Research Papers

Analysis of COVID-Related Patents for Antibodies and Vaccines
 Research Paper 173, 7 February 2023

By Kausalya Santhanam
Directives pour l’examen des demandes de brevet relatives aux produits pharmaceutiques
 Document de Recherche No. 171, 31 janvier 2023

Par Carlos M Correa
Pautas para el Examen de Solicitudes de Patentes Relacionadas con Productos Farmacéuticos
 Documento De Investigación 171, 29 De Noviembre De 2022

Por Carlos M Correa
View all research papers

SouthNews

Reunión Regional de Alto Nivel sobre Políticas de Propiedad Intelectual para Favorecer el Logro de los Objetivos de Salud Pública (Cartagena, dic. 5-6) organizado en cooperación con el Ministerio de Salud y Protección Social de Colombia
 SouthNews No. 440, 31 de enero de 2023

Viviana Muñoz Téllez

Second Global Forum on Intellectual Property, Access to Medicines and Innovation Report
 SouthNews No. 435, 20 January 2023

Vitor Ido
South Centre Statement on the extension of the TRIPS waiver for diagnostics and therapeutics for COVID-19
 SouthNews No. 434, 9 January 2023
View all SouthNews

SouthViews

Competition Law and Intellectual Property: A Study Drawing from The Eli Lilly Case on ‘Sham Litigation’ in Brazil
 SouthViews No. 240, 1 September 2022

By Pablo Leurquin
Doha Twenty Years On – Has The Promise Been Betrayed?
 SouthViews No. 238, 20 June 2022

By Yousuf Vawda and Bonginkosi Shozi
The WTO TRIPS Waiver and Essential Security Rights in 2022
 SouthViews No. 235, 10 March 2022

By Dr. Alexander Beyleveld
View all SouthViews

Training Papers

Propiedad intelectual y acceso a medicamentos: una introducción a cuestiones clave – algunos términos y conceptos básicos
 Material de Capacitación 1, Junio 2021

Por Germán Velásquez
Propriété Intellectuelle et Accès aux Médicaments : Une Introduction aux Grandes Problématiques – Quelques Termes et Concepts de Base
 Documents de Formation 1, Août 2020

Par Germán Velásquez
Intellectual Property and Access to Medicines: An Introduction to Key Issues – Some Basic Terms and Concepts
 Training Paper 1, December 2019

Dr. Germán Velásquez
View all training papers

Statements

South Centre Statement on the extension of the TRIPS waiver for diagnostics and therapeutics for COVID-19
 9 January 2023
WHO, WIPO & WTO Trilateral Symposium 2022 South Centre Opening Statement
 16 December 2022

by Viviana Munoz Tellez
South Centre Statement
WHO proposed instrument on pandemics: the Conceptual Zero Draft needs substantial improvement to address global public health needs
 9 December 2022
View all statements

Other Publications

South Centre Comments on the Draft Annotated Outline of a WHO Convention, Agreement or Other International Instrument on Pandemic Prevention, Preparedness and Response
 24 June 2022
A New Treaty on Pandemics: Some Key Issues from a Global South Perspective
 Working Paper, 23 November 2021

By Tamara Luciana Bustamante, Josefina del Rosario Lago, Mariana Magliolo, & Lucas Javier Segal, Facultad de Derecho, Universidad de Buenos Aires
Scope of Compulsory License and Government Use of Patented Medicines in the Context of the COVID-19 Pandemic
 March 2021
View all other publications